![4-[1,1′-Biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-1-piperazinehexanamide](https://static.cymitquimica.com/cas-image/348739-4-11-biphenyl-2-yl-n-4-cyanophenyl-methyl-1-piperazinehexanamide.png)
CAS: 1052147-86-0 - 4-[1,1′-Biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-1-piperazinehexanamide
Formula:C30H34N4O
InChI:InChI=1S/C30H34N4O/c31-23-25-14-16-26(17-15-25)24-32-30(35)13-5-2-8-18-33-19-21-34(22-20-33)29-12-7-6-11-28(29)27-9-3-1-4-10-27/h1,3-4,6-7,9-12,14-17H,2,5,8,13,18-22,24H2,(H,32,35)
InChI key:InChIKey=BQEDZLDNNBDKDS-UHFFFAOYSA-N
SMILES:N#CC1=CC=C(C=C1)CNC(=O)CCCCCN2CCN(C=3C=CC=CC3C=4C=CC=CC4)CC2
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | LP-211 REF: TM-T5387CAS: 1052147-86-0 | 99.7% | 46,00 €~680,00 € | Lun 15 Lug 24 |
 | LP-211 REF: TR-L473405CAS: 1052147-86-0 | - - - | 2.137,00 € | Mar 20 Ago 24 |
 | LP-211 REF: 3D-CSB14786CAS: 1052147-86-0 | Min. 95% | Prezzo su richiesta | Lun 19 Ago 24 |
LP-211
CAS:1052147-86-0
LP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM), and …
Formula:
C30H34N4O
Purezza:
99.7%
Colore e forma:
Solid
Peso molecolare:
466.62
Ref: TM-T5387
| 2mg | 46,00 € | ||
| 5mg | 69,00 € | ||
| 10mg | 94,00 € | ||
| 25mg | 177,00 € | ||
| 50mg | 301,00 € | ||
| 100mg | 476,00 € | ||
| 200mg | 680,00 € | ||
| 1ml*10 (DMSO) | 75,00 € |
Consegna stimata in Stati Uniti, il Lunedì 15 Luglio 2024
LP-211
Prodotto ControllatoCAS:1052147-86-0
Formula:
C30H34N4O
Colore e forma:
Neat
Peso molecolare:
466.617
Ref: TR-L473405
| 500mg | 2.137,00 € |
Consegna stimata in Stati Uniti, il Martedì 20 Agosto 2024
LP-211
CAS:1052147-86-0
LP-211 is a drug that binds to the 5-hydroxytryptamine 7 receptor (5-HT7) with high affinity …
Formula:
C30H34N4O
Purezza:
Min. 95%
Peso molecolare:
466.62 g/mol
Ref: 3D-CSB14786
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 19 Agosto 2024
